Tjan-Heijnen VC - Search Results

1

Multicenter validation of a gene expression-based prognostic signature in lymph node-negative primary breast cancer.

Foekens JA, Atkins D, Zhang Y, Sweep FC, Harbeck N, Paradiso A, Cufer T, Sieuwerts AM, Talantov D, Span PN, Tjan-Heijnen VC, Zito AF, Specht K, Hoefler H, Golouh R, Schittulli F, Schmitt M, Beex LV, Klijn JG, Wang Y. Foekens JA, et al. J Clin Oncol. 2006 Apr 10;24(11):1665-71. doi: 10.1200/JCO.2005.03.9115. Epub 2006 Feb 27. J Clin Oncol. 2006. PMID: 16505412

2

Cutaneous infection due to Mycobacterium abscessus. A case report.

Vogels MT, Tjan-Heijnen VC, Alkemade JA, Beex LV, Muytjens HL. Vogels MT, et al. Acta Derm Venereol. 1997 May;77(3):222-4. doi: 10.2340/0001555577222224. Acta Derm Venereol. 1997. PMID: 9188876 Free article.

3

[Chemotherapy in metastasized breast cancer].

Beex LV, Tjan-Heijnen VC, Ottevanger PB. Beex LV, et al. Ned Tijdschr Geneeskd. 1999 Jan 2;143(1):59-60. Ned Tijdschr Geneeskd. 1999. PMID: 10086103 Dutch. No abstract available.

4

Micro-metastases in axillary lymph nodes: an increasing classification and treatment dilemma in breast cancer due to the introduction of the sentinel lymph node procedure.

Tjan-Heijnen VC, Buit P, de Widt-Evert LM, Ruers TJ, Beex LV. Tjan-Heijnen VC, et al. Breast Cancer Res Treat. 2001 Nov;70(2):81-8. doi: 10.1023/a:1012938825396. Breast Cancer Res Treat. 2001. PMID: 11768607 Review.

5

The prognostic value of vascular endothelial growth factor in 574 node-negative breast cancer patients who did not receive adjuvant systemic therapy.

Manders P, Beex LV, Tjan-Heijnen VC, Geurts-Moespot J, Van Tienoven TH, Foekens JA, Sweep CG. Manders P, et al. Br J Cancer. 2002 Sep 23;87(7):772-8. doi: 10.1038/sj.bjc.6600555. Br J Cancer. 2002. PMID: 12232762 Free PMC article.

6

The prognostic value of the mitotic activity index in patients with primary breast cancer who were not treated with adjuvant systemic therapy.

Manders P, Bult P, Sweep CG, Tjan-Heijnen VC, Beex LV. Manders P, et al. Breast Cancer Res Treat. 2003 Jan;77(1):77-84. doi: 10.1023/a:1021138801890. Breast Cancer Res Treat. 2003. PMID: 12602906

7

Stage migration in breast cancer: surgical decisions concerning isolated tumour cells and micro-metastases in the sentinel lymph node.

de Widt-Levert L, Tjan-Heijnen V, Bult P, Ruers T, Wobbes T. de Widt-Levert L, et al. Eur J Surg Oncol. 2003 Apr;29(3):216-20. doi: 10.1053/ejso.2002.1401. Eur J Surg Oncol. 2003. PMID: 12657229

8

Cyclin-E is a strong predictor of endocrine therapy failure in human breast cancer.

Span PN, Tjan-Heijnen VC, Manders P, Beex LV, Sweep CG. Span PN, et al. Oncogene. 2003 Jul 31;22(31):4898-904. doi: 10.1038/sj.onc.1206818. Oncogene. 2003. PMID: 12894232

9

Vascular endothelial growth factor is associated with the efficacy of endocrine therapy in patients with advanced breast carcinoma.

Manders P, Beex LV, Tjan-Heijnen VC, Span PN, Sweep CG. Manders P, et al. Cancer. 2003 Nov 15;98(10):2125-32. doi: 10.1002/cncr.11764. Cancer. 2003. PMID: 14601081 Free article.

10

Vascular endothelial growth factor independently predicts the efficacy of postoperative radiotherapy in node-negative breast cancer patients.

Manders P, Sweep FC, Tjan-Heijnen VC, Geurts-Moespot A, van Tienoven DT, Foekens JA, Span PN, Bussink J, Beex LV. Manders P, et al. Clin Cancer Res. 2003 Dec 15;9(17):6363-70. Clin Cancer Res. 2003. PMID: 14695136

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

310 results

Search Page

Filters